OOIR: Observatory of International Research

Papers

(The H4-Index of Dermatologic Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	105
Issue Information	90
Exploring and expanding frontiers in dermatology: Indigenous African dermatology	81
Macrophage Migration Inhibitory Factor and Gene Polymorphism (rs755622G>C) in Unstable Vitiligo Patients	68
Ultraviolet A Combined with Narrow‐Band Ultraviolet B is an Effective Treatment Modality for Early Folliculotropic Mycosis Fungoides and Early Mycosis Fungoides Refractory to Narrow‐Band Ultraviolet B	53
Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series	51
Topical Timolol for ingrown nail post‐avulsion refractory wound	50
Two birds with one stone: Successful treatment with methotrexate in a patient with generalized eruptive keratoacanthoma of Grzybowski and rheumatoid arthritis	49
Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the “minimal disease activity” parameter	44
Seroconversion after anti‐SARS‐CoV ‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals	44
Epidemiology, clinical presentation, and management of pemphigoid nodularis: An update from Iran	42
Ulcerative injection site reaction after third COVID ‐19 vaccine dose with mRNA ‐1273	41
New‐onset systemic lupus erythematosus after ChAdOX1 nCoV‐19 and alopecia areata after BNT162b2 vaccination against SARS‐CoV‐2	40
Cutaneous lupus erythematosus variants responsive to J anus kinase inhibition	39
Fat herniation over striae distansea in focal dermal hypoplasia treated with 2940 nm Er: YAG Laser	36
Tofacitinib in resistant chronic actinic dermatitis: A case series	35
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al.	35
Combined treatment with omalizumab and secukinumab in a patient with chronic spontaneous urticaria and psoriasis	35
Comparison of Green‐Synthesized Silver Nanoparticle Shampoo Created by Moringa and Bergamot Extraction Versus 2% Ketoconazole Shampoo for Scalp Seborrheic Dermatitis: A Prospective, Randomized, Double	34
Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry	34
Cryptococcal meningitis associated with interleukin‐17 inhibitor use for psoriasis	32
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis	30
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib	30
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication	29
Microneedle fractional radiofrequency for atrophic acne scars: In vivo evaluation of results by 3D analysis and reflectance confocal microscopy	29

	27
	27
The case of granuloma annulare associated with SARS‐CoV ‐2 infection	27